摘要
子宫内膜癌是女性常见恶性肿瘤之一,发病率逐年上升且呈年轻化趋势.分子分型的提出突破了传统Bokhman二分类的局限,通过探索分子学特征促进了子宫内膜癌的精准诊断、风险分层及靶向治疗.在分子分型的发展背景下,激素治疗作为毒性低、性价比高、患者依从性高的传统治疗方式,其价值应重新被评估.
Abstract
Endometrial cancer is one of the most common gynecological cancers,with an annually increasing inci-dence rate and a trend of harassing younger women than before.The introduction of molecular classification has over-come the limitations of the traditional Bokhman division,facilitating precise diagnosis,risk stratification,and targeted therapy of endometrial cancer by exploring molecular features.In the era of molecular classification,hormone therapy,as a traditional treatment characterized by low toxicity,high cost-effectiveness,and high patient compliance,should be redefined for the value.
维普
万方数据